Full text is available at the source.
Abstract
Resveratrol may restrain the activation of the NLRP3 inflammasome, which is associated with chronic inflammation.
- Chronic inflammation contributes to various diseases, including inflammatory bowel disease and neurodegenerative disorders.
- The NLRP3 inflammasome is crucial for activating inflammatory molecules like Interleukin-1β and Interleukin-18.
- Resveratrol is explored for its potential to inhibit NLRP3 inflammasome activation.
- Understanding the mechanisms of resveratrol could open therapeutic avenues for managing inflammation-related diseases.
Simplified